Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
Following the approval of Toripalimab by the Food and Drug Administration, two more Chinese-made cancer drugs have received approval for distribution in the US.
Some of it may just be random. But there’s some logic to parts of it. I. This case the suffix -mab indicates that this drug is a monoclonal antibody.